Stay updated on Safety Study of AFM11 in NHL Clinical Trial
Sign up to get notified when there's something new on the Safety Study of AFM11 in NHL Clinical Trial page.

Latest updates to the Safety Study of AFM11 in NHL Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page changes from a 403 Forbidden screen to the ClinicalTrials.gov record for the AFM11 study, displaying its study details, eligibility criteria, locations, design, outcomes, and record history.SummaryDifference42%

- Check19 days agoChange DetectedThe footer now identifies the site as revision v3.8.0 instead of v3.7.2. The page content remains a 403 Forbidden error.SummaryDifference0.2%

- Check33 days agoChange DetectedAn NIH website-transition announcement banner appears above the 403 error page, and the site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check40 days agoChange DetectedThe ClinicalTrials.gov site revision label in the footer changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check61 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the previous study record content and removing core sections such as conditions, eligibility criteria, and locations.SummaryDifference16%

- Check68 days agoChange DetectedThe study record's revision label was updated from v3.6.6 to v3.7.0, indicating a new page revision. This update does not change the underlying study information or results.SummaryDifference0.1%

Stay in the know with updates to Safety Study of AFM11 in NHL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Study of AFM11 in NHL Clinical Trial page.